SRSF6 and cancer: After a deep literature analysis for each candidate, the splicing factor SRSF6 was highlighted as a good potential therapeutic target with regards to its role in proliferation and invasion in breast cancer [17], as unfavourable prognostic marker in multiple cancer types [19] and due to the existence of molecules to target it.